Evidence map›Paper›PMID 34366713›Full record

ArticleMediators of inflammation2021

Hengtao Xie, Yingying Chen, Wei Wu, Xiaobo Feng, Kairong Du

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Antioxidant and Anti-Inflammatory Effects of CrudeAntioxidants (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. SIRT1: A promising therapeutic target for chronic pain.CNS neuroscience & therapeutics · 2022
    Review
  8. Oxidative medicine and cellular longevity · 2022
    Article
  9. The effects of freshFrontiers in pharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hengtao XieDepartment of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, 430071 Hubei, China.
Yingying ChenDepartment of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, 430071 Hubei, China.
Wei WuDepartment of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, 430071 Hubei, China.
Xiaobo FengDepartment of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, 430071 Hubei, China.
Kairong DuDepartment of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, 430071 Hubei, China.ORCID https://orcid.org/0000-0003-3536-4501
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vincristine (Vin) is a well-known antitumor agent that frequently evokes neuropathic pain and decreases the quality of life of patients. Polysaccharides (GBP) extracted from

Indexed as

AnimalsBehavior, AnimalCytokinesGanglia, SpinalGastrodiaHyperalgesiaInflammationMaleMonosaccharidesNeuralgiaNeuroinflammatory DiseasesPolysaccharidesRatsRats, Sprague-DawleyRNA, MessengerSciatic NerveCytokinesMonosaccharidesPolysaccharidesRNA, MessengerSirt1 protein, ratSirtuin 1Vincristine

Identifiers

PMID34366713
PMCPMC8337128
OpenAlexW3186842814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.